Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Intraocular Lymphoma 1

Interventions

Rituximab 17 Peripheral Blood Stem Cell Transplantation 15 Cyclophosphamide 15 fludarabine phosphate 12 Whole-Body Irradiation 11 Cyclosporine 10 Mycophenolic Acid 9 Etoposide 9 Methotrexate 8 Filgrastim 8 Lenalidomide 7 Tacrolimus 6 Dexamethasone 6 Busulfan 6 Radiotherapy 5 Melphalan 5 Cytarabine 5 Carboplatin 5 Vorinostat 4 Thiotepa 4 Therapeutics 4 Psychiatric Rehabilitation 4 Bortezomib 4 Antilymphocyte Serum 4 Transplantation 3 Methylprednisolone 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Flow Cytometry 3 Dasatinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Intraocular Lymphoma × Lens Implantation, Intraocular × Lymphoid × Clear all

NCT03157375 2017-05-17

Rot P261

Medical University of Vienna

Phase NA Completed

Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡